Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,127Revenue $M6,418Net Margin (%)2.4Altman Z-Score3.3
Enterprise Value $M10,914EPS $1.4Operating Margin %6.9Piotroski F-Score6
P/E(ttm)62.5Beneish M-Score-2.9Pre-tax Margin (%)4.9Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %-0.5Quick Ratio1.2Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %3.3Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow16.9y-y EBITDA Growth Rate %31.3ROA % (ttm)2.5Higher Current Ratio y-yN
Dividend Yield %0.9PEG15.1ROE % (ttm)6.0Less Shares Outstanding y-yY
Payout Ratio %45.0Shares Outstanding M96.9ROIC % (ttm)6.2Gross Margin Increase y-yN

Gurus Latest Trades with OCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OCRJoel Greenblatt 2015-03-31 Buy 0.2%$72.5 - $78.77
($75.96)
$ 94.1724%New holding337,773
OCRJames Barrow 2015-03-31 Reduce$72.5 - $78.77
($75.96)
$ 94.1724%Reduce 0.13%4,801,304
OCRJoel Greenblatt 2014-12-31 Sold Out -0.31%$60.42 - $73.73
($68.02)
$ 94.1738%Sold Out0
OCRJoel Greenblatt 2014-09-30 Add0.28%$61.43 - $66.49
($63.51)
$ 94.1748%Add 929.98%501,043
OCRJoel Greenblatt 2014-06-30 Add0.04%$57.54 - $66.51
($62.07)
$ 94.1752%Add 1336.68%48,646
OCRJoel Greenblatt 2014-03-31 Reduce-0.01%$56.55 - $64.54
($60.65)
$ 94.1755%Reduce 71.62%3,386
OCRWallace Weitz 2013-12-31 Sold Out -0.24%$53.81 - $60.39
($57.24)
$ 94.1765%Sold Out0
OCRJoel Greenblatt 2013-12-31 Reduce-0.14%$53.81 - $60.39
($57.24)
$ 94.1765%Reduce 86.30%11,932
OCRWallace Weitz 2013-09-30 Reduce-1.19%$47.68 - $56.28
($53.39)
$ 94.1776%Reduce 84.78%113,700
OCRFirst Eagle Investment 2013-09-30 Reduce-0.16%$47.68 - $56.28
($53.39)
$ 94.1776%Reduce 55.65%851,300
OCRJoel Greenblatt 2013-09-30 Buy 0.16%$47.68 - $56.28
($53.39)
$ 94.1776%New holding87,071
OCRWallace Weitz 2013-06-30 Reduce-1.37%$40.82 - $47.97
($44.74)
$ 94.17110%Reduce 52.62%746,920
OCRHOTCHKIS & WILEY 2013-06-30 Sold Out -0.29%$40.82 - $47.97
($44.74)
$ 94.17110%Sold Out0
OCRJoel Greenblatt 2013-06-30 Sold Out -0.25%$40.82 - $47.97
($44.74)
$ 94.17110%Sold Out0
OCRJoel Greenblatt 2013-03-31 Buy 0.25%$36.1 - $40.72
($38.52)
$ 94.17144%New holding122,850
OCRHOTCHKIS & WILEY 2012-12-31 Reduce-0.03%$32.98 - $36.59
($34.83)
$ 94.17170%Reduce 9.79%1,435,189
OCRJoel Greenblatt 2012-12-31 Sold Out -0.02%$32.98 - $36.59
($34.81)
$ 94.17171%Sold Out0
OCRJames Barrow 2012-12-31 Reduce$32.98 - $36.59
($34.83)
$ 94.17170%Reduce 0.06%3,965,780
OCRJoel Greenblatt 2012-09-30 Reduce-0.1%$30.68 - $35.53
($32.29)
$ 94.17192%Reduce 80.66%10,660
OCRJoel Greenblatt 2012-06-30 Buy 0.13%$29.5 - $36.01
($33.2)
$ 94.17184%New holding55,131
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


OCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HEYER STEVEN JDirector 2015-03-05Buy6,630$75.4624.79view
Wallman AmyDirector 2015-03-02Sell1,874$77.4421.6view
Wallman AmyDirector 2014-08-20Sell5,672$63.8447.51view
Kraft Robert O.SVP & CFO 2014-05-06Buy1,500$6056.95view
Sahney NitinPresident & COO 2014-04-30Buy10,000$58.4961view
Sahney NitinPresident & COO 2014-04-30Buy10,000$58.4961view
Carpenter Randall ASVP and CIO 2013-05-24Sell17,587$45.85105.39view
Stamps Jeffrey MEVP & President, LTC Ops 2012-11-05Sell40,560$35.36166.32view
Sahney NitinCOO & President, SCG 2012-08-03Buy10,000$32194.28view
Workman John LInterim CEO, President & CFO 2012-07-30Buy5,000$31.14202.41view

Quarterly/Annual Reports about OCR:

News about OCR:

Articles On GuruFocus.com
CVS Eyeing Omnicare Acquisition To Bolster Market Position May 23 2015 
CVS To Buy Out Omnicare For $10.4 Billion May 22 2015 
Glenview Capital Raises Stake In Monsanto May 21 2015 
phone Dec 18 2014 
It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 
Steven Romick’s Third Quarter Sells at FPA Crescent Fund Oct 17 2013 
Waiting for Gold Rain, Wally Weitz Does "Unnaturally Well" Sep 23 2013 
First Pacific Advisors’ Major Selling and Reductions in Second Quarter Aug 15 2013 
Steven Romick Comments on Omnicare Jul 29 2013 
Steven Romick on WealthTrack Oct 20 2012 

More From Other Websites
McKesson Sees Healthy Growth In Prescription Drugs Jun 25 2015
Pittsburgh Business Group on Health-CVS contract could save members $75M on drug costs Jun 25 2015
CVS President Helena Foulkes on how a tobacco-free CVS plans to make up $2B in lost revenue Jun 23 2015
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest Jun 19 2015
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest Jun 19 2015
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest Jun 19 2015
CVS' Omnicare Merger Creates a Muscular Stake in Medicare Jun 17 2015
CVS Hits Bull's-Eye With Target Pharmacy Deal Jun 15 2015
European stocks close higher Jun 11 2015
OMNICARE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 05 2015
Cardinal Health to buy generics distributor for $1.12 bln Jun 05 2015
Omnicare (OCR) Stock Falling on Analyst Downgrade Jun 04 2015
Goldman Sachs Downgrades Omnicare, 'Revisiting Valuation' Jun 04 2015
Omnicare downgraded by Goldman Jun 04 2015
Target CEO: Elevated focus on style Jun 01 2015
RxCrossroads adding nearly 100 jobs in Louisville Jun 01 2015
RxCrossroads Seeks Qualified Candidates for Nearly 100 Positions as Growth Continues Jun 01 2015
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Omnicare, Inc.... May 27 2015
‘Merger Monday’ now falls on Tuesday, Wednesday or even Thursday May 27 2015
OMNICARE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout May 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK